The TU-025 keishibukuryogan clinical trial for hot flash management in postmenopausal women: Results and lessons for future research

Menopause

Volumn 18, Issue 8, 2011, Pages 886-892

  Plotnikoff, Gregory A ^a,b,c   Watanabe, Kenji ^b   Torkelson, Carolyn ^c   La Valleur, June ^c   Radosevich, David M ^c  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alternative medicine; Herbal medicine; Hot flash; Menopause

Indexed keywords

KEISHI BUKURYO GAN; TU 025; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; GREENE CLIMACTERIC INDEX; HOT FLUSH; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MAYO CLINIC HOT FLASH DIARY; MAYO HOT FLASH SCORE; PHASE 2 CLINICAL TRIAL; PITTSBURG SLEEP QUALITY INDEX; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP; TREATMENT OUTCOME; UNITED STATES;

DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HEALTH STATUS INDICATORS; HOT FLASHES; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; POSTMENOPAUSE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80051546925     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31821643d9     Document Type: Article

References (30)

1. Rapp SR, Espeland MA, Shumaker SA, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2663-2672. (Pubitemid 37430137)
2. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662. (Pubitemid 37430136)
3. Chelbowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 2003; 289:3242-3253.
4. Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimes of hormone therapy and risk of breast cancer. JAMA 2003;289:3254-3263. (Pubitemid 37430078)
5. Beral V, Million Women Study Coordinators. Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet 2003;362: 419-427. (Pubitemid 36999703)
6. Grady D, Gebrestsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gyencol 1995;85:304-313.
7. Miller J, Chan BK, Nelson HD. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and metaanalysis for the U.S. Preventive Services Task Force. Ann Intern Med 2002;136:680-690. (Pubitemid 34462681)
8. Hulley S, Furberg C, Barrett-Connor F, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. HERS II. JAMA 2002; 288:58-66.
9. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:242-255.
10. Menes TS, Kerlikowske K, Jaffer S, Seger D, Milioretti DL. Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: finding from the Breast Cancer Surveillance Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:2822-2828.
11. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007;9:R28.
12. Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304:1684-1692.
13. Ishibashi A, Kosoto H, Ohno S, et al. General introduction to Kampo. In: The Japanese Society of Oriental Medicine, ed. Introduction to Kampo, Japanese Traditional Medicine. Tokyo: Elsevier; 2005:2.
14. Nikkei Medical. Utilization survey of Kampo medicines. Nikkei Medical 2007;10:41-47.
15. Noguchi M, Yuzurihara M, Ikarashi Y. Effects of the vasoactive neuropeptides calcitonin geneYrelated peptide, substance P and vasoactive intestinal peptide on skin temperature in ovariectomized rats. Neuropeptides 2002;36:327-332. (Pubitemid 35440831)
16. Noguchi M, Ikarashi Y, Yuzurihara M, et al. Up-regulation of calcitonin gene-related peptide receptors underlying elevation of skin temperature in ovariectomized rats. J Endocrinol 2002;175:177-183. (Pubitemid 35276596)
17. Noguchi M, Ikarashi Y, Yuzirihara M, et al. Effects of the Japanese herbal medicine Keishi-bukuryo-gan and 17A-estradiol on calcitonin gene-related peptide-induced elevation of skin temperature in ovariectomized rats. J Endocrinol 2003;176:359-366. (Pubitemid 36410419)
18. Noguchi M, Ikarashi Y, Yuzurihara M, et al. Effects of 17A-estradiol and the Japanese herbal medicine Keishi bukuryo-gan on the release and synthesis of calcitonin gene-related peptide in ovariectomized rats. J Pharmacol Sci 2003;93:80-86. (Pubitemid 37254271)
19. Brown H, Prescott R. Applied Mixed Models in Medicine. Chichester, UK: John Wiley & Sons, 1999.
20. Dobson AJ. An Introduction to Generalized Linear Models. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC, 2002
21. Stokes ME, Davis CS, Koch GG. Categorical Data Analysis Using the SAS System. Cary, NC: SAS Institute Inc, 2000.
22. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlaxafine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000;356:2059-2063. (Pubitemid 32009821)
23. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289:2827-2834. (Pubitemid 37430118)
24. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280-4290. (Pubitemid 33096775)
25. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Med 1976;20:425-430.
26. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29: 25-31. (Pubitemid 28247565)
27. Buysee DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1998;28:193-213.
28. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45:5-13. (Pubitemid 28339935)
29. Moerman D. Meaning, Medicine and the FPlacebo Effect. Cambridge: Cambridge University Press, 2005.
30. Watanabe K, Matsuura K, Gao P, et al. Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicineV the state of research and methodological suggestions for the future. Evid Based Complement Altern Med 2010;doi:10.1093/ecam/neq067 accessed June 16, 2010.